Companies: 10,795·Total market cap: $144.5T
Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company

NUNZOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$43451
P/E Ratio—
52W High$0.003
52W Low$0.0001
SEC Filings

Nunzia Pharmaceutical Company (NUNZ) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000886093 · NUNZ · OTC · as of Jun 9, 2026

Filing snapshot

208
Total Filings
15-12G
Latest Form
2023-07-20
Most Recent
2009
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000886093 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2022-04-15
Fiscal Year End
Apr 15, 2022
Accession No.
0001683168-22-002707
Primary Document
nunzia_i10k-123121.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000886093 · Accession 0001683168-22-002707

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2022-11-14
View 10-Q on SEC
8-KCurrent Report
NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING
2022-03-18Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
FORM 15
2023-07-20
View
10-QQuarterly Report
FORM 10-Q
2022-11-14
View
10-QQuarterly Report
10-Q
2022-10-03
View
10-QQuarterly Report
QUARTERLY REPORT
2022-05-23
View
NT 10-QNT 10-Q
EXTENSION
2022-05-16
View
10-KAnnual Report
FORM 10-K
2022-04-15
View
NT 10-KNT 10-K
NT 10-K
2022-03-31
View
10-Q/AQuarterly Report (Amended)
AMENDMENT #1 TO FORM 10-Q
2022-03-29
View
10-Q/AQuarterly Report (Amended)
AMENDMENT #1 TO FORM 10-Q
2022-03-29
View
10-Q/AQuarterly Report (Amended)
AMENDMENT #1 TO FORM 10-Q
2022-03-29
View
10-K/AAnnual Report (Amended)
FORM 10-K/A
2022-03-29
View
8-KCurrent Report
NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING
2022-03-18
View
8-KCurrent Report
NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING
2022-03-02
View
10-QQuarterly Report
NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING
2021-11-10
View
10-QQuarterly Report
NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING
2021-09-17
View
Showing 1–15 of 153 filingsForm 4 / 144 hidden· 208 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000886093  |  Exchange: OTC · Healthcare

Nunzia Pharmaceutical Company (OTC: NUNZ) has submitted 208 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0000886093, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Nunzia Pharmaceutical Company's most comprehensive regulatory disclosure. The most recent Nunzia Pharmaceutical Company 10-K was filed on 2022-04-15 for fiscal year ending 2022. Historical NUNZ 10-K annual reports are available from 1997 through 2022.

Investors researching Nunzia Pharmaceutical Company SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
NNRX SEC Filings →QEBR SEC Filings →WIBFF SEC Filings →INSD SEC Filings →ARYX SEC Filings →VFRM SEC Filings →ATTBF SEC Filings →ISOLF SEC Filings →
→ NUNZ Financials→ NUNZ Earnings→ NUNZ Insider Trades

Frequently Asked Questions

NUNZ SEC Filings · 8 questions

Nunzia Pharmaceutical Company (NUNZ) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 208 filings and access original documents at no cost. Nunzia Pharmaceutical Company's CIK is 0000886093.

NUNZ SEC filingsNunzia Pharmaceutical Company SEC documentsfind NUNZ 10-K